Weekly versus biweekly bortezomib given in patients with indolent non-Hodgkin lymphoma: A meta-analysis
Table 2
Combined therapy and outcomes of studies included in the meta-analysis.
Click through the PLOS taxonomy to find articles in your field.
For more information about PLOS Subject Areas, click here.
Combined therapy and outcomes of studies included in the meta-analysis.
Our website uses different types of cookies. Optional cookies will only be set with your consent and you may withdraw this consent at any time. Below you can learn more about the types of cookies PLOS uses and register your cookie preferences.